Premium
Serum salbutamol concentrations during oral and intravenous treatment in pregnant women
Author(s) -
HAUKKAMAA MAIJA,
GUMMERUS MARTTI,
KLEIMOLA TERTTU
Publication year - 1985
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1985.tb04867.x
Subject(s) - salbutamol , medicine , anesthesia , pregnancy , pharmacology , asthma , biology , genetics
Summary. The serum concentration of salbutamol was determined in 29 pregnant women during oral treatment (4 mg five times per day) and in seven during intravenous infusion (6–30 μg/min) because of premature labour. The concentration of salbutamol was determined by combined gas‐liquid chromatography mass spectrometry. The mean concentration of serum salbutamol was twice as high during intravenous treatment (24; SD 9 ng/ml), than during oral treatment (12; SD 3 mg/ml). During oral treatment: the salbutamol levels were not correlated to maternal height, weight or the incidence or severity of side‐effects. The serum concentrations of salbutamol in patients with twin pregnancies did not differ from those with singleton pregnancies. After stopping intravenous treatment, serum salbutamol levels remained high for several hours and oral treatment can be started 4–6h after stopping intravenous infusion.